Page last updated: 2024-10-22

amantadine and Multiple Sclerosis, Relapsing-Remitting

amantadine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research Excerpts

ExcerptRelevanceReference
"The present research was intended to investigate the effectiveness of acupuncture plus amantadine compared with amantadine alone on fatigue in patients with relapsing-remitting MS (RRMS) in the remission stage of the disease."5.69Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial. ( Kazemi, AH; Khodaie, F; Naser Moghadasi, A; Zhao, B, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Khodaie, F1
Naser Moghadasi, A1
Kazemi, AH1
Zhao, B1

Trials

1 trial available for amantadine and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial.
    Acupuncture in medicine : journal of the British Medical Acupuncture Society, 2023, Volume: 41, Issue:4

    Topics: Acupuncture Therapy; Amantadine; Fatigue; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-

2023